Here, we examined the M2-type macrophage-inducing effects of KS-133 in vitro and the potent anti-tumor effects of KS-133 nanoparticles (NPs) when administered alone or combined with an anti-PD-1 antibody. The gene discussed is PDCD1; the disease is neoplasm.